We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Erasca

News List

Erasca Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares firstwordpharma
July 21, 2021
Erasca, Inc. (Nasdaq: ERAS) today announced the closing of its initial public offering of 21,562,500 shares of common stock, which includes the exercise in full by the underwriters of their option to purchase 2,812,500 additional shares.
Erasca picks up $42M to target biological drivers of cancer fiercebiotech
December 25, 2018
Erasca has raised a $42 million series A round from the likes of City Hill Ventures and Cormorant Asset Management to work toward the lofty goal to “not just treat, but actually cure cancer.” ....